Invention Grant
- Patent Title: Method of inhibiting FLT3 kinase
- Patent Title (中): 抑制FLT3激酶的方法
-
Application No.: US11550077Application Date: 2006-10-17
-
Publication No.: US07795279B2Publication Date: 2010-09-14
- Inventor: Shelley K. Ballentine , Christian Andrew Baumann , Jinsheng Chen , Carl R. Illig , Sanath K. Meegalla , M. Jonathan Rudolph , Robert W. Tuman , Mark J. Wall , Kenneth Wilson , Dana L. Johnson
- Applicant: Shelley K. Ballentine , Christian Andrew Baumann , Jinsheng Chen , Carl R. Illig , Sanath K. Meegalla , M. Jonathan Rudolph , Robert W. Tuman , Mark J. Wall , Kenneth Wilson , Dana L. Johnson
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agent Mary A. Appollina
- Main IPC: A61K31/445
- IPC: A61K31/445 ; C07D293/10
Abstract:
A method of reducing or inhibiting kinase activity of FLT3 in a cell or a subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to FLT3 using a compound of the present invention: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof. The present invention is further directed to methods for treating conditions such as cancers and other cell proliferative disorders.
Public/Granted literature
- US20070149572A1 METHOD OF INHIBITING FLT3 KINASE Public/Granted day:2007-06-28
Information query
IPC分类:
